
Sign up to save your podcasts
Or


This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
By Circulation, an American Heart Association Journal4.3
3030 ratings
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421

135 Listeners

319 Listeners

506 Listeners

163 Listeners

895 Listeners

299 Listeners

3,360 Listeners

135 Listeners

1,152 Listeners

197 Listeners

93 Listeners

517 Listeners

373 Listeners

439 Listeners

373 Listeners